New Ebola vaccine trial launches as outbreak spreads in DR Congo

AI Summary

A new clinical trial launched in the Democratic Republic of Congo will test the Zaire Ebolavirus vaccine Ervebo against the current Bundibugyo Ebola strain amid a spreading outbreak. The trial aims to evaluate vaccine efficacy and provide urgent protection in the outbreak region.

Clinical trial of the Zaire Ebolavirus vaccine Ervebo to be investigated against the current Bundibugyo strain.